Sandoz Glimepiride Recalled Due To Mislabelling Of Dosage Strength On Packaging

Sandoz Glimepiride Recall Summary Sandoz is recalling Glimepiride tablets across Canada because the packaging labels show incorrect dosage strengths that don't match what's actually in the bottles. This affects patients who take this diabetes medication and received packages with mislabeled dosages. The mislabeling could cause patients to take the wrong dose if they rely on the package information.

Category

consumer product recall

Country

Canada

Agency

HC-PRODUCTS

Recall date

2014-01-24

Status

Closed

Distribution

Canada-wide

Official recall notice from HC-PRODUCTS

Recall details on Nibble Recalls: https://trynibble.app/recalls/f7bd5d72-a3ac-4fe1-b7a3-a1497e02e982